| Application no. and date | 12700262.4 (espacenet) (Federated) (European Patent Register), 20120105 | | Patent/reg. no. and date | DK/EP 2661261, 20190731 | | Publication date | 20131113 | | Priority no. and date | EP 11150431, 20110107 | | EP pub. no. and date |
EP 2661261 20131113 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/159233 | | Inventor | BOUILLOT, Philippe, Novartis Pharma AG
Postfach
CH-4002 Basel, CH,
REYNAUD, Emeric, Novartis Pharma AG
CH-4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/397 (2006.01) , A61K 9/20 (2006.01) | | Title | Immunsuppressive formuleringer | | Int. application no. | EP2012050151 | | Int. publication no. | WO2012093161 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
